Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines
Clinical trial NCT05875701 · COMPLETED
Trial details
- NCT number
- NCT05875701
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2023-11-11
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.